RE: Anna11 Sep 2021 12:37
Trouble is Jay, looking at the way this is ran, there clearly is no plan.
They should have made sales, if the product is as good as stated and given they have approvals, someone, somewhere would buy it. If the price is an issue, do a deal and generate some revenue rather than dilute shareholders. I'd take selling millions of tests at reduced margins rather selling none at a high margin.
They are good at coming up with products but come up woefully short when it comes to sales ability and executing a sales strategy, if one exists.